Related Experiment Video
Updated: Jul 15, 2026

12:00
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
15.4K
Application and Performance of CT-Fractional Flow Reserve in Non-ST-Segment Elevation Myocardial Infarction
Josephine Warren1, Luke Dawson1, Tori McCollom2
1Department of Cardiology, Alfred Hospital, Melbourne, Australia.
The American Journal of Cardiology
|March 27, 2025
Summary
Computed tomography fractional flow reserve (CT-FFR) accurately rules out obstructive coronary artery disease (CAD) in myocardial infarction patients. This non-invasive method enhances diagnostic accuracy beyond standard CT angiography alone.
Area of Science:
- Cardiology
- Radiology
- Medical Imaging
Background:
- Non-ST-segment elevation myocardial infarction (NSTEMI) patients often lack obstructive coronary artery disease (CAD) on invasive angiography.
- A reliable non-invasive method to exclude obstructive CAD is needed for NSTEMI patients.
Purpose of the Study:
- To evaluate the diagnostic performance of computed tomography fractional flow reserve (CT-FFR) in NSTEMI patients.
- To compare CT-FFR accuracy against coronary computed tomography angiography (CCTA) alone and invasive methods.
Main Methods:
- Invasive coronary angiography (ICA) with fractional flow reserve (FFR) measurements served as the gold standard.
- CT-FFR was performed on coronary computed tomography angiography (CCTA) images prior to ICA in NSTEMI inpatients.
- CT-FFR and CCTA performance were assessed against ICA plus FFR for obstructive CAD detection.
Main Results:
- CT-FFR demonstrated strong correlation with invasive FFR (r=0.78).
- Per-vessel analysis showed high accuracy for CT-FFR (AUC 0.93), superior to CCTA alone (AUC 0.87).
- CT-FFR achieved 100% diagnostic accuracy on a per-patient basis.
Conclusions:
- CT-FFR significantly improves diagnostic accuracy for obstructive CAD in NSTEMI patients compared to CCTA alone.
- CT-FFR is a valuable non-invasive tool for NSTEMI evaluation, correlating well with invasive FFR.

